ondansetron has been researched along with carboplatin in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (61.29) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aamdal, S | 1 |
| Dickson, DS; Evans, BD; Harvey, VJ; Langley, GB; Mak, D; Mitchell, PL; Neave, LM | 1 |
| Bayliss, MA; Chong, SL; Retsas, S; Sagar, SM | 1 |
| Howells, N; Lambert, HE; McQuade, B; Rustin, GJ; Smith, DB | 1 |
| Grunberg, SM | 1 |
| Alvarez, O; Bedros, A; Call, SK; Convy, L; Cook, L; Freeman, A; Halverson, J; Kalbermatter, O; Mick, K; Volsch, J | 1 |
| Kossey, JL; Kwok, KK | 1 |
| du Bois, A; Karck, U; Madjar, H; Meerpohl, HG; Prömpeler, H; Thomssen, C; Vach, W | 1 |
| Goldspiel, BR; Kohler, DR | 1 |
| Fanning, J; Hilgers, RD | 1 |
| Goddard, M | 1 |
| Airoma, G; Arpinelli, F; Bianco, AR; Gridelli, C; Incoronato, P; Pepe, R | 1 |
| Cramer-Giraud, U; du Bois, A; Fiola, M; Glaubitz, M; Thomssen, C; Vach, W | 1 |
| Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 2 |
| Dombernowsky, P; Handberg, J; Hansen, M; Herrstedt, J; Schousboe, BM; Sigsgaard, T | 1 |
| Bushnell, W; Chawla, S; Friedman, C; Hainsworth, J; Hesketh, P; Markman, M; Perez, EA; Reeves, J; Sandbach, J | 1 |
| Nakanishi, M; Noguchi, M; Sawaguchi, K; Tsukada, H; Yabushita, H; Yamada, H | 1 |
| Miyamoto, Y; Oomasa, M; Teramachi, M; Tomiyama, K; Yagi, K | 1 |
| DuBeshter, B; Hickok, JT; Lipshultz, SE; Morrow, GR | 1 |
| Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
| Berg, S; Bernstein, M; Blaney, SM; Cherrick, I; Kuttesch, N; Murry, DJ; Salama, V | 1 |
| Kulp, B; Markman, M; Markman, MR; Peterson, G | 1 |
| Amamoo, MA; Bernard, S; Goodin, S; Kane, M; Laliberte, K; Lindley, C; McCune, J; Pham, T; Schell, M; Shord, S; Socinski, MA; Yowell, S | 1 |
| Bafaloukos, D; Bakogiannis, C; Bamias, A; Boukovinas, I; Christodoulou, C; Dimopoulos, MA; Fountzilas, G; Kalofonos, HP; Kosmidis, PA; Makatsoris, T; Nicolaides, C; Samantas, E; Skarlos, D; Syrigos, K; Xiros, N | 1 |
| Auvrignon, A; Chastagner, P; Corradini, N; Doz, F; Gentet, JC; Giraud, C; Leblond, P; Rey, E; Rubie, H; Treluyer, JM; Urien, S; Vassal, G | 1 |
| Balu, S; Buchner, D; Feinberg, B; Gilmore, J; Haislip, S; Jackson, J; Jain, G | 1 |
| Akkayagorn, L; Manchana, T; Rithirangsriroj, K | 1 |
| Asada, K; Enomoto, N; Fujisawa, T; Hayakawa, H; Imokawa, S; Inui, N; Karayama, M; Kuroishi, S; Masuda, M; Nakamura, Y; Suda, T; Suzuki, S; Toyoshima, M; Watanabe, H; Yamada, T; Yokomura, K | 1 |
| Beckford-Brathwaite, E; Camacho, E; Green, SA; Jordan, K; Khanani, S; Noga, SJ; Pong, A; Rapoport, BL; Weinstein, C | 1 |
21 trial(s) available for ondansetron and carboplatin
| Article | Year |
|---|---|
Reduction of carboplatin induced emesis by ondansetron.
Topics: Antiemetics; Carboplatin; Dysgerminoma; Female; Humans; Imidazoles; Male; Middle Aged; Nausea; Ondansetron; Ovarian Neoplasms; Testicular Neoplasms; Vomiting | 1991 |
A phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer. The North Thames Ovary Group.
Topics: Adult; Aged; Carboplatin; Epithelium; Female; Humans; Imidazoles; Middle Aged; Nausea; Ondansetron; Ovarian Neoplasms; Vomiting | 1991 |
Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cross-Over Studies; Dexamethasone; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Nausea; Neoplasms; Ondansetron; Placebos; Vomiting | 1995 |
Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Female; Humans; Ifosfamide; Middle Aged; Ondansetron; Ovarian Neoplasms; Time Factors; Uterine Cervical Neoplasms; Vomiting | 1994 |
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lorazepam; Metoclopramide; Ondansetron; Ovarian Neoplasms; Prochlorperazine; Severity of Illness Index; Single-Blind Method; Treatment Failure; Vomiting | 1994 |
Pattern of carboplatin-induced emesis. The German Ondansetron Study Group.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Clinical Protocols; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Severity of Illness Index; Vomiting | 1995 |
Low-dose intravenous ondansetron (8 mg) plus dexamethasone: an effective regimen for the control of carboplatin-induced emesis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Middle Aged; Ondansetron; Vomiting | 1997 |
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Severity of Illness Index; Treatment Outcome; Vomiting | 1997 |
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Vomiting | 1998 |
[Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
Topics: Administration, Oral; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Cross-Over Studies; Dexamethasone; Female; Humans; Metoclopramide; Ondansetron; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory | 1999 |
[Effect of ondansetron hydrochloride injection and tablet against nausea and vomiting in lung cancer patients receiving carboplatin].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Nausea; Ondansetron; Tablets; Vomiting, Anticipatory | 1999 |
Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea.
Topics: Aged; Antiemetics; Antineoplastic Agents; Autonomic Nervous System; Blood Pressure; Carboplatin; Cisplatin; Cold Temperature; Cyclophosphamide; Female; Humans; Metoclopramide; Middle Aged; Nausea; Ondansetron; Ovarian Neoplasms; Posture; Valsalva Maneuver | 1999 |
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Middle Aged; Ondansetron; Treatment Outcome; Vomiting | 2000 |
Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide:.
Topics: Aged; Anthracyclines; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ondansetron; Serotonin Antagonists; Vomiting | 2004 |
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cisplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Ondansetron; Paclitaxel; Patient Satisfaction; Prochlorperazine; Serotonin Antagonists; Treatment Outcome; United States; Vomiting | 2005 |
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Cimetidine; Deoxycytidine; Dexamethasone; Diphenhydramine; Female; Gemcitabine; Heart Diseases; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Ondansetron; Paclitaxel; Premedication; Proportional Hazards Models | 2008 |
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Carboplatin; Child; Child, Preschool; Cytochrome P-450 CYP3A; Dexamethasone; Drug Interactions; Etoposide; Humans; Infant; Models, Biological; Neoplasms; Nonlinear Dynamics; Ondansetron; Polymorphism, Single Nucleotide | 2011 |
Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients.
Topics: Acupuncture Therapy; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cross-Over Studies; Female; Genital Neoplasms, Female; Humans; Middle Aged; Nausea; Ondansetron; Paclitaxel; Vomiting | 2015 |
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Paclitaxel; Pemetrexed; Vomiting | 2016 |
Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Ondansetron; Vomiting | 2018 |
10 other study(ies) available for ondansetron and carboplatin
| Article | Year |
|---|---|
Can ondansetron hydrochloride (Zofran) enhance the nephrotoxic potential of other drugs?
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Carboplatin; Creatinine; Dexamethasone; Drug Synergism; Humans; Ondansetron | 1992 |
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dacarbazine; Humans; Imidazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1991 |
Making chemotherapy easier.
Topics: Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Imidazoles; Nausea; Ondansetron; Organoplatinum Compounds; Serotonin Antagonists; Vomiting | 1990 |
Anaphylactoid reactions associated with ondansetron.
Topics: Adult; Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Cyclophosphamide; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Male; Nausea; Ondansetron; Ovarian Neoplasms; Tibia | 1994 |
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Metoclopramide; Ondansetron; Research Design; Vomiting | 1994 |
The real costs of emesis.
Topics: Antiemetics; Carboplatin; Cisplatin; Drug Costs; Female; Humans; Metoclopramide; Ondansetron; Ovarian Neoplasms | 1993 |
Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Male; Nausea; Ondansetron; Vomiting | 1993 |
Influence of phenytoin on the disposition of irinotecan: a case report.
Topics: Adolescent; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Disease Progression; Drug Interactions; Enzyme Induction; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Melphalan; Mixed Function Oxygenases; Neoplasm Recurrence, Local; Ondansetron; Phenobarbital; Phenytoin; Pineal Gland; Pinealoma; Prodrugs; Salvage Therapy; Seizures | 2002 |
Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Serotonin Antagonists; Taxoids; Vomiting | 2002 |
Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Vomiting | 2012 |